Literature DB >> 8648138

The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation. Preponderance of IL-Ra detection.

C J Roberge1, P E Poubelle, A D Beaulieu, D Heitz, J Gosselin.   

Abstract

The present study investigated the effect of EBV on gene expression and protein synthesis of IL-1 and its natural IL-1R antagonist (IL-1Ra) in human peripheral blood neutrophils. EBV induced a rapid accumulation of IL-1 and IL-lRa mRNA in neutrophils that was associated with the later appearance of considerable amounts of IL-1alpha, IL-1beta, and IL-Ra proteins. Approximately 3200 and 610 times more IL-Ra than IL-1alpha a or IL-1beta, respectively, was secreted by neutrophils in response to EBV. The effect induced by EBV cannot reflect an overall metabolic activity of neutrophils, since EBV failed to induce granulocyte-macrophage OF synthesis. Heat-inactivated virus was unable to stimulate cytokine synthesis, whereas UV-irradiated virus retained the full IL-1- and IL-1Ra-inducing potential of the native particle. Furthermore, pretreatment of cells with cycloheximide or phosphonoacetic acid did not abrogate the effect of EBV, suggesting that EBV does not penetrate the cell, but that a virion's structural molecule is required to induce such an effect. In this respect, neutralization of the viral particles with the mAb 72A1, which is known to react with glycoprotein gp350 of the viral envelope, inhibits the production of IL-1 and IL-1Ra, suggesting that gp350 could be involved in this process. Thus, the elevated levels of IL-1Ra detected for EBV-stimulated neutrophils might be part of a mechanism used by the virus to evade the immune system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648138

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.

Authors:  Hugo Sousa; Alexandra M Santos; Raquel Catarino; Daniela Pinto; José Moutinho; Paulo Canedo; José Carlos Machado; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 3.  Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.

Authors:  Debora Martorelli; Elena Muraro; Anna Merlo; Riccardo Turrini; Damiana Antonia Faè; Antonio Rosato; Riccardo Dolcetti
Journal:  Clin Dev Immunol       Date:  2012-01-29

Review 4.  Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.

Authors:  Yong Shen; Suzhan Zhang; Ren Sun; Tingting Wu; Jing Qian
Journal:  Emerg Microbes Infect       Date:  2015-03-25       Impact factor: 7.163

5.  Cytokine and Chemokine Profiling in Patients with Hand, Foot and Mouth Disease in Singapore and Malaysia.

Authors:  Fiona Mei Shan Teo; Min Nyo; Anng Anng Wong; Natalie Woon Hui Tan; Mia Tuang Koh; Yoke Fun Chan; Chia Yin Chong; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

6.  Epstein-Barr Virus Promotes the Production of Inflammatory Cytokines in Gingival Fibroblasts and RANKL-Induced Osteoclast Differentiation in RAW264.7 Cells.

Authors:  Sho Yokoe; Akira Hasuike; Norihisa Watanabe; Hideki Tanaka; Hiroyuki Karahashi; Shin Wakuda; Osamu Takeichi; Takayuki Kawato; Hideki Takai; Yorimasa Ogata; Shuichi Sato; Kenichi Imai
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.